Home > Insider Trading > Filing (0000899243-21-034586)

Filing Details

Accession Number:: 0000899243-21-034586
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-08-31 16:05:14
Reporting Period:: 2021-08-30

Accepted Time:: 2021-08-31 16:05:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
31791	Perkinelmer Inc	PKI	Laboratory Analytical Instruments (3826)	042052042

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1519218	Andrew Okun	940 Winter Street Waltham MA 02451	Please See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-08-30	3,054	$81.29	11,306	No	4	M	Direct
Common Stock	Disposition	2021-08-30	200	$184.16	11,106	No	4	S	Direct
Common Stock	Disposition	2021-08-30	126	$185.24	10,980	No	4	S	Direct
Common Stock	Disposition	2021-08-30	800	$186.72	10,180	No	4	S	Direct
Common Stock	Disposition	2021-08-30	1,328	$188.02	8,852	No	4	S	Direct
Common Stock	Disposition	2021-08-30	600	$188.85	8,252	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	NQ Stock Option (right to buy)	Disposition	2021-08-30	3,054	$0.00	3,054	$81.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2025-01-30	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8	Indirect	By 401(K)

Footnotes

The Exercise Price included on the Form 4 filed on February 1, 2018 for the Reporting Person was incorrectly reported due to administrative error.
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Okun on July 29, 2021.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $184.05 to $184.27. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $185.11 to $185.27. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $186.32 to $187.15. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $187.36 to $188.24. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $188.44 to $189.26. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
This option became exercisable in three equal annual installments beginning on January 30, 2019, which was the first anniversary of the date on which the option was granted.